Company Overview
About Pathway Genomics
Pathway Genomics (also known as Pathway OME) is a privately held clinical genetic testing company founded in 2008 and headquartered in San Diego, California. The company operates a CAP-accredited and CLIA-certified clinical laboratory that provides physicians and patients with actionable, precision healthcare information derived from genetic analysis. Pathway's testing services cover cancer risk assessment, cardiac health, pharmacogenomics (drug response), inherited disease risk, nutrition and exercise response, and reproductive health — enabling personalized healthcare decisions grounded in genetic data.
Business Model & Competitive Advantage
Pathway Genomics serves both direct-to-physician and direct-to-consumer channels, providing clinically validated genetic insights that help healthcare providers optimize treatment plans and patients better understand their hereditary health risks. The company's cancer risk panels assess pathogenic variants associated with conditions including hereditary breast and ovarian cancer (BRCA1/2), Lynch syndrome, and familial hypercholesterolemia. Its pharmacogenomics panels help physicians select appropriate medications and dosages based on individual genetic drug metabolism profiles, reducing adverse drug events.
Competitive Landscape 2025–2026
Pathway Genomics operates in a competitive genetic testing market alongside companies like Invitae, GeneDx, Color, and Myriad Genetics. The company differentiates through its broad multi-panel testing menu, its CLIA/CAP accreditation ensuring clinical-grade accuracy, and its physician-facing portal that integrates genetic insights into clinical workflows. While the company remains privately held and has a smaller profile than some genetic testing peers, it continues to serve an active network of physicians and patients seeking actionable genetic health information.
Key Differentiators
Strong Challenger
Pathway Genomics is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.
Frequently Asked Questions
Similar Brands
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Illumina
Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat
BioNTech
BioNTech SE was founded in 2008 in Mainz, Germany by Ugur Sahin, Ozlem Tureci, and Christoph Huber with a mission to harness the immune system for individualized cancer treatment. The company pioneere
Pliant Therapeutics
Pliant Therapeutics develops small molecule integrin inhibitors targeting the pathological tissue scarring (fibrosis) that drives diseases including idiopathic pulmonary fibrosis (IPF), primary sclero
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Genentech
Genentech was founded in 1976 in South San Francisco by Herbert Boyer and Robert Swanson, becoming the first company to produce human insulin using recombinant DNA technology and essentially launching
Compare Pathway Genomics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Pathway Genomics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Pathway Genomics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Pathway Genomics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →